Individualizing gentamicin dosage regimens in burn patients with gram‐negative septicemia: A cost‐benefit analysis

J. Lyle Bootman, Albert I. Wertheimer, Darwin Zaske, Clayton Rowland

Research output: Contribution to journal › Article › peer-review

80 Scopus citations

Fingerprint

Dive into the research topics of 'Individualizing gentamicin dosage regimens in burn patients with gram‐negative septicemia: A cost‐benefit analysis'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology

Keyphrases